跳至主要内容
临床试验/NCT04826484
NCT04826484终止3 期

A Randomized Trial Evaluating Use of Long-Acting Liposomal Bupivacaine (Exparel®) in Reducing Narcotic Pain Requirements in Pediatric Patients Undergoing Minor Urologic Procedures

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2021年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
104
试验地点
1
主要终点
Percentage of Patients Who Are Opiate-free

研究概览

简要总结

This study aims to evaluate the utility of long-acting liposomal bupivacaine (Exparel®) in improving pain scores and reducing narcotic pain requirements in pediatric patients following minor urologic procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pediatric patients 6 years and older undergoing minor pediatric urologic surgery
  • Patients who are otherwise eligible to receive routine care following minor urologic surgery

排除标准

  • Contraindication to receiving local anesthetics (i.e. pre-existing cardiac, renal, hepatic dysfunction)
  • Pediatric patients younger than 6 years of age
  • Pediatric patients with a history of pain syndromes or are unable to tolerate opiate medication
  • Unwilling to participate in 48 hours and 10-14 day follow-up phone calls

研究组 & 干预措施

Liposomal Bupivacaine plus 0.25% Bupivacaine

Experimental

Participants will receive local wound infiltration with sequential Liposomal Bupivacaine plus 0.25% Bupivacaine

干预措施: Exparel 133 miligrams per 10 milliliter injection (Drug)

Liposomal Bupivacaine plus 0.25% Bupivacaine

Experimental

Participants will receive local wound infiltration with sequential Liposomal Bupivacaine plus 0.25% Bupivacaine

干预措施: Bupivacaine Hydrochloride (Drug)

0.25% Bupivacaine alone

Active Comparator

Participants will receive local wound infiltration with 0.25% Bupivacaine alone.

干预措施: Bupivacaine Hydrochloride (Drug)

结局指标

主要结局

Percentage of Patients Who Are Opiate-free

时间窗: 48 hours postoperatively

Percentage of patients who are opiate-free at 48 hours postoperatively.

Percentage of Patients Who Are Opiate-free at 10-14 Days Postoperatively

时间窗: 10-14 days postoperatively

Percentage of patients who are opiate-free at 10-14 days postoperatively.

Parents' Postoperative Pain Measure (PPPM) Scores

时间窗: 10-14 days postoperatively

15-item, yes/no behavioral checklist based on non-verbal pain cues children show following surgery. Scale is from 0 to 15, with higher scores denoting more severe pain. A score of 6+ has been validated as a threshold for a child experiencing clinically significant pain.

次要结局

  • Percentage of Patients With Leftover Opioid Medication(10-14 days postoperatively)
  • Amount of Opioid Medication Used Post-discharge(10-14 days postoperatively)
  • Cumulative Incidence of Complications Related to Local Anesthetic Systemic Toxicity(10-14 days postoperatively)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验